Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Rockwell Medical Announces FDA Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Rockwell Medical Announces FDA Approval

For Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis

By: Betsy Louda

, Contract Pharma

Rockwell Medical provided an update regarding Calcitriol, the Company’s FDA approved active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. 

On July 11, 2018, Rockwell Medical received FDA approval of its Prior Approval Supplement for manufacturing Calcitriol. This approval was necessary in order to market and commercialize Calcitriol in the United States. Calcitriol is FDA approved under an Abbreviated New Drug Application and is manufactured through a contract manufacturing organization.  As previously announced, the Company submitted a manufacturing update to the FDA to approve the CMO and the FDA had provided a target date for a response to Rockwell Medical’s submission no later than August 19, 2018.
 
Rockwell will provide additional information regarding its plans for commercial production and sales of Calcitriol in the United States as it moves forward. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics